Health In Tech (NASDAQ:HIT – Get Free Report) was upgraded by equities research analysts at Maxim Group to a “strong-buy” rating in a report released on Thursday, Marketbeat Ratings reports. The brokerage presently has a $2.50 target price on the stock. Maxim Group’s target price indicates a potential upside of 212.34% from the stock’s previous close.
Separately, Wall Street Zen lowered Health In Tech from a “strong-buy” rating to a “buy” rating in a research note on Saturday, June 7th.
Get Our Latest Stock Analysis on Health In Tech
Health In Tech Trading Up 5.3%
Health In Tech (NASDAQ:HIT – Get Free Report) last issued its quarterly earnings results on Monday, April 14th. The company reported $0.01 earnings per share for the quarter, missing analysts’ consensus estimates of $0.02 by ($0.01). The business had revenue of $8.02 million during the quarter, compared to the consensus estimate of $6.87 million.
Institutional Investors Weigh In On Health In Tech
Institutional investors have recently bought and sold shares of the business. XTX Topco Ltd purchased a new position in shares of Health In Tech in the 1st quarter valued at $59,000. Cubist Systematic Strategies LLC purchased a new position in Health In Tech in the first quarter valued at about $41,000. Arete Wealth Advisors LLC acquired a new position in shares of Health In Tech during the first quarter worth about $47,000. Finally, Jane Street Group LLC acquired a new position in shares of Health In Tech during the first quarter worth about $48,000.
Health In Tech Company Profile
Health in Tech, Inc engages in the provision of insurance technology platforms which offer a marketplace of processes in the healthcare industry. Its services include Stone Mountain Risk, eDIYBS, HI Card, HI Performance Network, and Ancillary Products. The company was founded by Tim Johnson in 2014 and is headquartered in Stuart, FL.
Featured Stories
- Five stocks we like better than Health In Tech
- How to Profit From Value Investing
- Tesla: The Next Month Could Make or Break the Year
- How to Invest in Blue Chip Stocks
- Skyworks Stock Down 16% in 2025, Poised for AI Edge Surge
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Astera Labs: AI Infrastructure Play With Significant Growth Ahead
Receive News & Ratings for Health In Tech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Health In Tech and related companies with MarketBeat.com's FREE daily email newsletter.